[1]
K. Novin and N. Mortazavi, “Methodological Consideration for Clinical Development of Bevacizumab Biosimilar Candidate”, Reports-of-Radiotherapy-and-Onco, vol. 5, no. 1, pp. 1-2, Mar. 2019.